Ernexa Therapeutics ERNA
NASDAQ ERNA
$1.93 -0.08 (-3.98%)
At close: Nov 11, 2026 · 4:00 PM EST

Ernexa Therapeutics (ERNA) Cash from Discontinued Operations (2009 - 2019)

Updated

Ernexa Therapeutics (ERNA) reported Cash from Discontinued Operations of $26,000 for Q3 2011, compared with -$107,000 a year earlier.

Analysis

Ernexa Therapeutics (ERNA) Cash from Discontinued Operations (2009 - 2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discont. Ops (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 6.56 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Ernexa Therapeutics 3.31 Mn -18.41 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2019 -273,000.00
Mar 31, 2018 -226,000.00
Mar 31, 2016 -504,000.00
Dec 31, 2015 -1.88 Mn
Mar 31, 2015 995,000.00
Dec 31, 2014 -2.95 Mn
Sep 30, 2014 -1.45 Mn
Jun 30, 2014 -1.54 Mn
Mar 31, 2014 -453,000.00
Dec 31, 2013 672,000.00
Sep 30, 2013 758,000.00
Jun 30, 2013 -165.69 Mn
Mar 31, 2013 166.00 Mn
Dec 31, 2012 1.16 Mn
Mar 31, 2012 255,000.00
Dec 31, 2011 -119,000.00
Sep 30, 2011 26,000.00
Jun 30, 2011 -111,000.00
Mar 31, 2011 -96,000.00
Dec 31, 2010 -123,000.00
API Access

Ernexa Therapeutics Cash from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-discontinued-operations&ticker=ERNA&period=max&api_key=YOUR_API_KEY